Aytu Biopharma (AYTU) Goodwill (2015 - 2022)

Aytu Biopharma (AYTU) has reported Goodwill for 7 consecutive years, with $8.6 million the latest figure, recorded in Q1 2022.

• On a quarterly basis, Goodwill fell 77.1% year-over-year to $8.6 million in Q1 2022; TTM through Mar 2022 was $8.6 million, a 77.1% decrease from a year earlier, with the FY2021 full-year figure at $65.8 million, up 134.25% from the prior year.
• Goodwill was $8.6 million for Q1 2022 at Aytu Biopharma, down from $46.3 million in the prior quarter.
• Over five years, Goodwill peaked at $65.8 million in Q2 2021 and troughed at $8.6 million in Q1 2022.
• A 4-year average of $32.9 million and a median of $28.1 million in 2020 frame the typical range for Goodwill.
• Across the five-year window, Goodwill jumped 134.25% in 2021 and slumped 77.1% in 2022, its largest moves.
• Over 4 years, Goodwill stood at $15.4 million in 2019, then soared by 82.56% to $28.1 million in 2020, then surged by 65.0% to $46.3 million in 2021, then sank by 81.37% to $8.6 million in 2022.
• The last three Goodwill figures came in at $8.6 million (Q1 2022), $46.3 million (Q4 2021), and $46.3 million (Q3 2021), per Business Quant data.